Advances in Cancer Immunotherapy™️ Webinar: Clinical Updates from ESMO Immuno-Oncology Congress 2019

When:  Jun 9, 2020 from 1:00 PM to 2:00 PM (ET)
aci17-sitc-clr.jpgOn June 9, 2020 join leading experts in cancer immunotherapy as they discuss the latest advances in cancer immunotherapy emerging from ESMO Immuno-Oncology Congress 2019. This is a FREE CME-, CNE-, CPE- and MOC- certified webinar intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. To view full accreditation information, click here.

Click here to register for this webinar.

Webinar Faculty
  • Joshua Brody, MD – Icahn School of Medicine at Mount Sinai
  • Ezra Cohen, MD – University of California San Diego
  • Tanja de Gruijl, PhD (moderator) – VU University Medical Center
  • Geoffrey Gibney, MD – Georgetown Lombardi Comprehensive Cancer Center

Webinar Agenda:
1:00–1:05 p.m. EDT Overview: Welcome and Introductions
1:05–1:40 p.m. EDT Presentation
1:40–1:55 p.m. EDT Question and Answer Session
1:55–2:00 p.m. EDT Closing Remarks

Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.

Postgraduate Institute for MedicineSITC Logo



The 2019–2020 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.


The 2019–2020 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Celgene Corporation, Exelixis, Inc., Genentech, Incyte Corporation and Merck & Co., Inc.